Authors


Bhavani Patel, PharmD

Latest:

THE PHARMACEUTICAL INDUSTRY: CONTRIBUTING TO BETTER MEDICINES

Drs. Patel, Singh, and Whalen are postdoctoral fellows in the Rutgers Pharmaceutical Industry Fellowship Program. Dr. Alexander is director of the Institute for Pharmaceutical Industry Fellowships, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey. Dr. Barone is professor and chair of the Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey.


Carmela Avena-Woods BS Pharm, PharmD, BCGP

Latest:

3 Words Nobody Should Say in the Pharmacy

Each day you encounter patients with multiple and various disease states, alignments, and questions. For some, questions they initially didn’t think they even had.


Soham Shukla, PharmD Candidate 2019

Latest:

Taking on AMCP Nexus: A First-Time Conference Experience

As one of Academy of Managed Care Pharmacy’s two annual conventions, AMCP Nexus aims to provide in-depth educational programming on the current advances and challenges in managed care.


Katherine E. MacDonald, PharmD candidate

Latest:

Status Epilepticus: When Benzodiazepine Fails to Elicit Response

SE requires prompt intervention to terminate seizure activity to prevent neuronal damage and complications.


Elizabeth C. DiMaggio, PharmD Candidate

Latest:

Prescription Drug Adherence: A "Challenge" for So Many…

Poor medication compliance in chronic diseases in a well-known public health problem. Pharmacists play a key role in optimizing medication use in patients with chronic conditions.


Douglas Hillblom, PharmD

Latest:

No Simple Answers for Lowering Drug Costs

Although there is a persistent need for lower prescription drug costs, this simple concept is complicated by multiple factors.


Stuart Deal, PharmD, RPh

Latest:

Health System Specialty Pharmacy: Benefits to Oncology Prescription Turnaround Times

Prior authorization (PA) requirements, cost, and other factors can lead to turnaround times of up to 3 weeks, delaying the start of therapy and creating substantial anxiety for patients.


Gunda Siska, PharmD

Latest:

Monday Pharmaceutical Mystery: How Did Getting Healthy and Losing Weight Result in Kidney Failure?

RG is a male patient aged 45 years who has arrived at the pharmacy to pick up his regular maintenance medications after recently losing 45 pounds in 3 months.



Erica Lindsay, PharmD, MBA, Esq.

Latest:

Consistency Is Vital When Conducting Internal Investigations

Make sure that all individuals involved are exposed to the same process and treated equally, even though the infractions may differ.


Ronald W. Lanton III, Esq

Latest:

Will a New Utah Law Change the DIR Conversation?

Although there has been an increasing amount of legislation regarding it, as well, the Utah legislature has taken a very different approach.


G. Caleb Alexander, MD, MS

Latest:

Prescribing Patterns of Novel Anticoagulants Within a Statewide Multispecialty Practice

While warfarin remains the most commonly prescribed anticoagulant, novel anticoagulant use appears to be increasing especially among cardiologists. With new indications for these agents, uptake in prescribing by primary care providers is likely to increase.



Katelyn O'Brien, PharmD

Latest:

Pharmacist Management of Alpelisib-Associated Hyperglycemia

The selection of an agent for hyperglycemia management requires knowledge of both the efficacy and the potential adverse effects of each possible agent, so choosing the best therapy for any given patient can be complicated.


Emily Shor, PharmD

Latest:

FDA Adds Novel Antimicrobials to Arsenal

Antimicrobial resistance continues to pose a significant health threat, necessitating new antibiotics with novel mechanisms to treat these complicated infections. However, between 2010 and 2018, newly approved antibiotics were primarily derived from previously established drug classes. This past summer, the FDA approved 2 new antibiotics.


Jeffrey R. Curtis, MD, MS, MPH

Latest:

Effectiveness and Costs of Biologics in Veterans With Rheumatoid Arthritis

This study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.


Laura T. Pizzi, PharmD, MPH, RPh

Latest:

Diabetes Quality Measurement: A Primer for Pharmacists

The continuing education article reviews diabetes quality improvement efforts and the potential for expanding the role of pharmacists as clinical care providers.


Jeffrey Lombardo, PharmD, BCOP

Latest:

Highlighting the Risk of Occupational Exposure to Hazardous Drugs in the Health Care Setting

The health care setting has the largest and most diverse array of agents that are hazardous to humans.


Eric Sredzinski, PharmD, AAHIVP

Latest:

Limiting the Distribution of Oncology Drugs

Approximately 80% of manufacturers are already managing their products, many of which are oncology drugs, through a limited distribution model.



Sam Mikhli, PharmD Candidate

Latest:

Many Options Now Available to Treat Hyperlipidemia

Adherence to both pharmacologic and nonpharmacologic regimens will result in the largest impact on hyperlipidemia, and patients should be individually assessed to determine the most appropriate ones for them.


Advocacy–Oncology, Walgreens

Latest:

The Role of the Pharmacist as Part of a Multidisciplinary Cancer Care Team

The high-level monitoring required for self-managing patients with cancer becomes a challenge when patients are seen less frequently by their provider.


Joseph S. Van Tuyl, PharmD, BCPS

Latest:

Antibiotic Treatment of Endocarditis

Patients who received ampicillin and ceftriaxone were less likely to have new onset renal failure.



John Meehan, PharmD, MSPBA

Latest:

How Will Value-Based Contracting Influence the Future of Specialty Pharmacy?

Pharma manufacturers in the future will reimburse payers on payments for ineffective therapies based on outcomes.



Jeff S. Baird, Esq

Latest:

Landmark Supreme Court Ruling: State Regulation of PBM Reimbursement Rates

Supreme Court ruling clears the way for states to pass laws that protect pharmacies from predatory reimbursement practices by PBMs.


Liisa Palmer, PhD

Latest:

Web Exclusive: Real-World Anti-TNF Dose Escalation in Patients With Crohn's Disease

This study evaluated the rates of dose escalation in patients with Crohn's disease.


Travis Wolff, PharmD

Latest:

Community Pharmacists Make a Difference With Immunizations

Despite some challenges, these programs increase rates and follow-up doses and improve patient communication.


Michael J. Hennessy

Latest:

Pharmacy Students Prepare for Changing Health Care Landscape

It is more important than ever to have pharmacists and pharmacy professionals practicing at the top of their license to assist patients in pharmacy deserts.